Concert Pharmaceuticals CNCE

$ 8.37 0.0%

Quarterly report 2022-Q3
added 11-07-2022

Concert Pharmaceuticals Cash and Cash Equivalents 2011-2024 | CNCE

Annual Cash and Cash Equivalents Concert Pharmaceuticals

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
142 M	77.2 M	53 M	17.8 M	27.7 M	40.6 M	92.5 M	13.4 M	9.64 M	7.49 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
142 M	7.49 M	48.1 M

Quarterly Cash and Cash Equivalents Concert Pharmaceuticals

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	95.2 M	-	59.4 M	142 M	104 M	122 M	89.8 M	77.2 M	77.2 M	77.2 M	77.2 M	53 M	53 M	53 M	53 M	17.8 M	17.8 M	17.8 M	17.8 M	27.7 M	27.7 M	27.7 M	27.7 M	40.6 M	40.6 M	40.6 M	40.6 M	92.5 M	92.5 M	92.5 M	92.5 M	13.4 M	13.4 M	13.4 M	13.4 M	9.64 M	9.64 M	9.64 M	9.64 M	7.49 M	-	-	-	22.9 M	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
142 M	7.49 M	49.2 M